This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
T cells are very potent cancer-fighting cells in our immune system, and are often used in cell-based immunotherapies. Dr. Gerlach is helping to decipher their various identities and behaviors. She is searching for markers on the T cells that delineate cells with different functional properties.
Harvard Medical School | All Cancers | 2014 | Ulrich H. von Andrian, M.D.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
CRI scientists will highlight cancer immunotherapy advances in the clinic at the 2021 ASCO annual meeting.